Balci, M. Et Al. 2015. Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.47, no.3 , 473-477.

Balci, M., Tuncel, A., Guzel, O., Aslan, Y., Sezgin, T., Bilgin, O., ... Senel, C.(2015). Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.47, no.3, 473-477.

Balci, Melih Et Al. "Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.47, no.3, 473-477, 2015

Balci, Melih Et Al. "Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.47, no.3, pp.473-477, 2015

Balci, M. Et Al. (2015) . "Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.47, no.3, pp.473-477.

@article{article, author={Melih Balci Et Al. }, title={Use of the nuclear matrix protein 22 Bladder Chek test (TM) in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2015, pages={473-477} }